Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000251537 is an artificial or concatenated annotation from the Ensembl and GeneCards databases corresponding to a region that covers the tripartite motif-containing 16 (TRIM16) gene and the CMT1A duplicated region transcript 1 (CDRT1). The full name combines these two otherwise distinct genetic entities and may reference an annotated locus containing both; however, this does not correspond to a known protein or functional molecular target. No literature or external databases recognize or validate "Novel tripartite motif-containing 16 and CMT1A duplicated region transcript 1 protein" as a standalone molecule. Neither TRIM16 nor CDRT1 individually are major therapeutic targets, and the combined entry is not used functionally or diagnostically in clinical or research settings. Expression data is available for this locus in cancer tissues, but does not link to functional roles or clinical applications.
None. As there are no drugs interacting with this target, mechanism(s) of action are not defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel tripartite motif-containing 16 and CMT1A duplicated region transcript 1 protein (ENSG00000251537).